Current Liabilities Endring Dato
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Adma Biologics USD 49.81M 7.96M 2023-12
ALKERMES USD 503.11M 15.92M 2023-09
Alterity Therapeutics Limited AUD 4.38M 849.82K 2023-06
AstraZeneca USD 28.59B 2.21B 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Clal Biotechnology ILS 2.91M 173K 2022-12
Compugen USD 10.38M 425K 2023-09
CSL USD 4.61B 278.2M 2023-06
Dynavax Technologies USD 62.2M 7.93M 2023-12
Eli Lilly USD 22B 3.08B 2023-09
Esperion Therapeutics USD 137.71M 30.54M 2023-09
GlaxoSmithKline GBP 22.39B 282M 2023-09
Grifols EUR 2.03B 148.07M 2023-09
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
J&J USD 44.37B 9.8B 2023-09
Marinus Pharmaceuticals USD 30.56M 4.95M 2023-09
Merck USD 23.09B 300M 2023-09
Minerva Neurosciences USD 3.35M 1.44M 2023-09
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Novavax USD 1.47B 127.66M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Roche Holding CHF 26.21B 1.03B 2023-06
Takeda JPY 2.37T 134.12B 2023-09
Vanda Pharmaceuticals USD 87.4M 6.4M 2023-06



Minerva Neurosciences Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.